<DOC>
	<DOCNO>NCT01773655</DOCNO>
	<brief_summary>The goal protocol determine prevalence somatic germline mutation BAP1 ( BRCA associate protein-1 ) among patient mesothelioma , choroidal nevus , primary uveal melanoma ( UM ) , metastatic UM see institution .</brief_summary>
	<brief_title>Clinical Histopathologic Characteristics BAP1 Mutations</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Uveal Neoplasms</mesh_term>
	<criteria>All consent : &gt; = 18 year age Ability provide inform consent Consent 1 : Mesothelioma Histologically proven diagnosis Mesothelioma OR Choroidal nevus Diagnosis choroidal nevus direct examination and/or ultrasound/optical coherence tomography possibly fluorescein angiography OR Primary uveal melanoma Diagnosis uveal melanoma direct examination and/or ultrasound/optical coherence tomography possibly fluorescein angiography Consent 2 : Mesothelioma Histologically proven diagnosis Mesothelioma AND BAP1 mutation loss expression identify tumor sample OR one following : Age &lt; 50 diagnosis No history asbestos exposure Personal history choroidal nevus , uveal melanoma , melanoma , renal cell carcinoma , cholangiocarcinoma Family history choroidal nevus , uveal melanoma , mesothelioma , renal cell carcinoma , cholangiocarcinoma History malignancy two firstdegree relative OR Choroidal nevus Diagnosis choroidal nevus direct examination and/or ultrasound/optical coherence tomography possibly fluorescein angiography AND one following : More one clinical risk factor , may include : orange pigment , thickness &gt; 1 &lt; 2.5mm Personal history uveal melanoma , skin melanoma , mesothelioma renal cell carcinoma , cholangiocarcinoma Family history choroidal nevus , uveal melanoma , mesothelioma renal cell carcinoma , cholangiocarcinoma OR Primary uveal melanoma Diagnosis uveal melanoma direct examination and/or ultrasound/optical coherence tomography possibly fluorescein angiography AND one following : Personal history uveal melanoma , skin melanoma , mesothelioma , renal cell carcinoma , cholangiocarcinoma Family history choroidal nevus , uveal melanoma , mesothelioma , renal cell carcinoma , cholangiocarcinoma History malignancy two firstdegree relative OR Metastatic uveal melanoma Histologically proven diagnosis metastatic uveal melanoma AND BAP1 mutation loss expression identify tumor sample OR one following : Personal history uveal melanoma , skin melanoma , mesothelioma renal cell carcinoma , cholangiocarcinoma Family history choroidal nevus , uveal melanoma , mesothelioma renal cell carcinoma , cholangiocarcinoma History malignancy two firstdegree relative Consent 3 : Relative patient germline BAP1 mutation identify identified testing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>somatic</keyword>
	<keyword>germline</keyword>
	<keyword>mutation</keyword>
	<keyword>BAP1 ( BRCA associate protein-1 )</keyword>
	<keyword>12-235</keyword>
</DOC>